Industry, GPOs Urge Dems Not To Confuse Compounding, Drug Shortage Issues

Two drug manufacturers and a trade group representing group purchasing organizations are pushing back against a recent request by House Democrats for Congress' investigative arm to probe the relationship between drug compounding, drug shortages and GPOs.

Source found here.  Subscription required.

Committee Leaders Request Documents from Drug Compounding Industry Association | Congressman Henry Waxman

Committee Leaders Request Documents from Drug Compounding Industry Association | Congressman Henry Waxman

Another Lawsuit Against NECC: Peay v.NECC

http://dockets.justia.com/docket/tennessee/tnmdce/3:2012cv01259/54707/

Black holes and gray areas: State, federal authorities take a closer look at pharmacy compounding | Drug Store News

Black holes and gray areas: State, federal authorities take a closer look at pharmacy compounding | Drug Store News

Florida Board will Revisit Franck's Lab and Anazao Health Corp cases at Dec. 11-12th meeting

Here is a summary:

A. Chair's Report - Cynthia Griffin, PharmD, Chair
1. Dr. Cynthia Griffin – Short Term Priority List
a. Emergency Rule
b. Re-visit Cases with Sterile Compounding Issues
i.
Franck’s Lab, Inc d/b/a Franck’s Compounding Pharmacy
ii.
Anazao Health Corp
c. Inspector Training
d. Non-Resident Pharmacies Compliance with Florida Law
e. Possible Requirement of FL Pharmacist in Non-Resident Pharmacy
f. USP Standards – Physician Exemptiong. Collaboration with other Professional Boards
h. Proposed Legislation
i. Disciplinary Guidelines
2. Dr. Michele Weizer
a. USP 797 Beyond Use Date (BUD)

To view complete agenda click here